DOCSLIB.ORG

Review Article the Smith-Lemli-Opitz Syndrome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review Article the Smith-Lemli-Opitz Syndrome J Med Genet 2000;37:321–335 321 Review article J Med Genet: first published as 10.1136/jmg.37.5.321 on 1 May 2000. Downloaded from The Smith-Lemli-Opitz syndrome Richard I Kelley, Raoul C M Hennekam Abstract genitalia. In all informative families, segregation The Smith-Lemli-Opitz syndrome (SLOS) of either form of SLOS was consistent with is one of the archetypical multiple congeni- autosomal recessive inheritance.212The genetic tal malformation syndromes. The recent cause of the disorder was not suspected for many discovery of the biochemical cause of years, although by the mid 1980s a number of SLOS and the subsequent redefinition of abnormalities of steroid metabolism in SLOS SLOS as an inborn error of cholesterol had been reported, including enlarged, lipid metabolism have led to important new depleted adrenal glands17 and aberrant patterns treatment possibilities for aVected pa- of steroid sulphates in plasma and urine.12 17 18 tients. Moreover, the recent recognition of Nevertheless the primary defect remained un- the important role of cholesterol in verte- known until Natowicz and Evans19 found that a brate embryogenesis, especially with re- patient with SLOS had essentially undetectable gard to the hedgehog embryonic signalling levels of normal urinary bile acids. An analysis of pathway and its eVects on the expression of that patient’s plasma sterols led to the homeobox genes, has provided an explana- discovery20 that the patient had a more than tion for the abnormal morphogenesis in 1000-fold increase in the level of the syndrome. The well known role of chol- 7-dehydrocholesterol (cholesta-5,7-dien-3beta- esterol in the formation of steroid hor- ol; 7DHC), suggesting a deficiency of mones has also provided a possible 7-dehydrocholesterol reductase (DHCR7), the explanation for the abnormal behavioural final step in the Kandutsch-Russell cholesterol characteristics of SLOS. biosynthetic pathway.21 The same sterol pattern (J Med Genet 2000;37:321–335) has subsequently been found in most patients with either type of SLOS, as well as in patients http://jmg.bmj.com/ Keywords: Smith-Lemli-Opitz syndrome; cholesterol with variant syndromes that could not be metabolism; 7-dehydrocholesterol reductase; clinical history; management assigned the diagnosis of SLOS on clinical grounds alone.22 23 Although initial evidence suggested that the human gene for SLOS was History located at 7q32.1, the human DHCR7 gene was The Smith-Lemli-Opitz syndrome was first later cloned and localised to chromosome described in 1964 by the late David Smith, the 11q12-13 by Moebius et al.24 Shortly afterwards, on September 30, 2021 by guest. Protected copyright. Belgian paediatrician Luc Lemli, and John three groups independently reported apparently 1 Opitz in a report of three patients who had in disabling mutations of DHCR7 in patients with common a distinctive facial appearance, micro- SLOS.24–26 cephaly, broad alveolar ridges, hypospadias, a characteristic dermatoglyphic pattern, severe feeding disorder, and global developmental Table 1 Findings in 167 clinically diagnosed cases of The Johns Hopkins Smith-Lemli-Opitz syndrome compared with 164 University, Kennedy delay. A more complete delineation of SLOS biochemically confirmed cases Krieger Institute, 707 was presented in 1969 as the “RSH syndrome”, North Broadway, a non-descriptive acronym of the first letters of Clinically Biochemically Baltimore, Maryland 2 diagnosed confirmed the original patients’ surnames. The description Finding (%) (%) 21205, USA of many new cases of SLOS over the next 20 R I Kelley years expanded the known characteristics of the Mental retardation 97 95 Postnatal growth retardation 85 82 Institute for Human syndrome, especially in the recognition of multi- Microcephaly 80 84 2–11 Genetics and ple internal anomalies (table 1). Many Structural brain anomalies 60 37 Department of aVected children died in the first year from fail- Ptosis 69 70 Cataract 23 22 Paediatrics, Academic ure to thrive and infections, but many others Anteverted nares 90 78 Medical Centre, survived to adulthood. Somewhat later, several Cleft palate* 51 47 University of authors described patients with a lethal syn- Congenital heart defect 50 54 Amsterdam, Abnormal lung lobation 40 45 Meibergreef 15, 1105 drome that resembled SLOS, and which they Pyloric stenosis 15 14 12–16 AZ Amsterdam, designated “type II SLOS”. These children Colonic aganglionosis 12 16 Renal anomalies 40 43 The Netherlands had many of the anomalies found in SLOS, but Genital anomalies 74 65 R C M Hennekam died in the newborn period from internal 2/3 toe syndactyly 85 97 malformations. Moreover, most 46,XY “males” Polydactyly† 52 48 Correspondence to: Dr Hennekam, with so called type II SLOS had severe *Includes cleft soft palate, submucous cleft, and cleft uvula. [email protected] hypogenitalism or female appearing external †Includes postaxial polydactyly of hand(s)/foot. 322 Kelley, Hennekam Clinical overview lar genetic studies confirmed that the diVer- GENERAL ences in severity between types I and II SLOS J Med Genet: first published as 10.1136/jmg.37.5.321 on 1 May 2000. Downloaded from Although most published reports of SLOS are explained by the severity of the mutations describe only a single patient or a small number responsible. However, these results do not pre- of patients, there are a few exceptions in which clude the existence of genetic heterogeneity in 10 or more cases are described.2 9 12 23 27–29 Fur- SLOS; recently two mildly aVected sibs were thermore, several excellent older reviews found to have probably a related but biochemi- exist.10 15 30 A tabulation of the major clinical cally diVerent disorder of sterol metabolism.33 features of patients described in suYcient detail is provided in table 1. A comparison of INCIDENCE the most common characteristics of patients The earliest estimate of the incidence of SLOS ascertained by clinical v biochemical diagnosis was made by Lowry and Yong,34 who found an shows similar frequencies of the physical incidence in British Columbia of 1/40 000 anomalies. Only structural brain anomalies and births and a carrier frequency of 1%. The inci- anomalies of the genitalia are somewhat more dence in that survey increased to 1/20 000 common in the clinically diagnosed group. births when suspected but less definite cases Before the recognition of the biochemical cause were included. The incidence in a completely of SLOS, several authors suggested division of ascertained newborn population in Middle Bohemia (Czech Republic) was estimated to be SLOS into the relatively less expressed type I 35 form and the more severe type II form.12 13 31 greater than 1 in 10 000. However, in contrast Curry et al12 cautiously suggested that type I to these relatively high incidences based exclu- and type II might diVer genetically, whereas sively on clinical diagnosis, the incidence of others thought the subdivision was not SLOS diagnosed biochemically in similar justified.32 To address this question, Bialer et populations appears to be much lower. For example, between 1995 and 1998, when al15 devised a scoring system to evaluate the knowledge of the biochemical defect was wide- clinical severity of SLOS. Upon scoring 122 spread, the two laboratories that perform at published cases, they found a unimodal least 80% of biochemical testing for SLOS in frequency distribution of the scores for various the United States identified only about 40 new anomalies, which was interpreted as evidence cases per year, or an estimated incidence of less for a continuum of severity in SLOS and than 1 in 60 000 births (Kelley and Tint, against a genetic distinction between types I unpublished data). Similarly, estimates of only and II SLOS. However, because length of sur- 1 in 60 000 newborns in the United vival was part of the original scoring in addition Kingdom,27 1 in 80 000-100 000 births in The to separate scores for individual visceral Netherlands (Waterham et al, unpublished anomalies, the original scoring system of Bialer 36 15 data), and an even lower incidence in Japan et al was overweighted for internal anomalies. have been reported. The number of cases with 23 37 38 39 40 Therefore, we (Kelley and Hennekam, unpub- African, Asian, or South American http://jmg.bmj.com/ lished data) modified the Bialer score, to ancestry is also low. Although there remains weight embryologically separate organ systems some uncertainty about the absolute incidence equally. The revised scoring system (table 2) of SLOS in some countries, there clearly are has been used in two series of biochemically strikingly diVerent incidences among various 23 27 confirmed cases and showed a continuum ethnic groups. Both heterozygote advantage of severity and strong correlations with various and founder eVect have been suggested to biochemical parameters. Subsequent molecu- explain the relatively higher incidence of SLOS on September 30, 2021 by guest. Protected copyright. Table 2 Adapted (from ref 15) severity score for anatomical abnormalities in among those of European descent. The per- Smith-Lemli-Opitz syndrome centage of patients born to consanguineous parents is relatively low for an autosomal reces- Organ Score Criteria sive entity,23 27 35 which suggests persistence in Brain 1 Seizures; qualitative MRI abnormality the population of multiple mutant alleles 2 Major CNS malformations; gyral defects through heterozygote advantage. Oral 1 Bifid uvula or submucous cleft 2 Cleft hard palate or median cleft lip Acral 0 Non-Y shaped minimal toe syndactyly CRANIOFACIAL CHARACTERISTICS 1 Y shaped 2/3 toe syndactyly; club foot; upper or lower In the following listing of cases with various polydactyly; other syndactyly 2 Any two of the above features, no indication is made of whether a Eye 2 Cataract; frank microphthalmia case was biochemically confirmed or not. In Heart 0 Functional defects general, cases published after 1994 will have 1 Single chamber or vessel defect 2 Complex cardiac malformation been biochemically confirmed, but in cases Kidney 0 Functional defect from earlier papers this remains unknown.
Load more

Recommended publications
  • Estrogen Receptor-Mediated Neuroprotection: the Role of the Alzheimer’S Disease-Related Gene Seladin-1
    REVIEW Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1 Alessandro Peri Abstract: Experimental evidence supports a protective role of estrogen in the brain. According Mario Serio to the fact that Alzheimer’s disease (AD) is more common in postmenopausal women, estrogen treatment has been proposed. However, there is no general consensus on the benefi cial effect of Department of Clinical Physiopathology, Endocrine Unit, estrogen or selective estrogen receptor modulators in preventing or treating AD. It has to be said that Center for Research, Transfer several factors may markedly affect the effi cacy of the treatment. A few years ago, the seladin-1 gene and High Education on Chronic, Inflammatory, Degenerative (for selective Alzheimer’s disease indicator-1) has been isolated and found to be down-regulated and Neoplastic Disorders in brain regions affected by AD. Seladin-1 has been found to be identical to the gene encoding the for the Development of Novel enzyme 3-beta-hydroxysterol delta-24-reductase, involved in the cholesterol biosynthetic pathway, Therapies (DENOThe), University β of Florence, Florence, Italy which confers protection against -amyloid-mediated toxicity and from oxidative stress, and is an effective inhibitor of caspase-3 activity, a key mediator of apoptosis. Interestingly, we found earlier that the expression of this gene is up-regulated by estrogen. Furthermore, our very recent data support the hypothesis that seladin-1 is a mediator of the neuroprotective effects of estrogen. This review will summarize the current knowledge regarding the neuroprotective effects of seladin-1 and the relationship between this protein and estrogen.
    [Show full text]
  • Supratentorial Brain Malformations
    Supratentorial Brain Malformations Edward Yang, MD PhD Department of Radiology Boston Children’s Hospital 1 May 2015/ SPR 2015 Disclosures: Consultant, Corticometrics LLC Objectives 1) Review major steps in the morphogenesis of the supratentorial brain. 2) Categorize patterns of malformation that result from failure in these steps. 3) Discuss particular imaging features that assist in recognition of these malformations. 4) Reference some of the genetic bases for these malformations to be discussed in greater detail later in the session. Overview I. Schematic overview of brain development II. Abnormalities of hemispheric cleavage III. Commissural (Callosal) abnormalities IV. Migrational abnormalities - Gray matter heterotopia - Pachygyria/Lissencephaly - Focal cortical dysplasia - Transpial migration - Polymicrogyria V. Global abnormalities in size (proliferation) VI. Fetal Life and Myelination Considerations I. Schematic Overview of Brain Development Embryology Top Mid-sagittal Top Mid-sagittal Closed Neural Tube (4 weeks) Corpus Callosum Callosum Formation Genu ! Splenium Cerebral Hemisphere (11-20 weeks) Hemispheric Cleavage (4-6 weeks) Neuronal Migration Ventricular/Subventricular Zones Ventricle ! Cortex (8-24 weeks) Neuronal Precursor Generation (Proliferation) (6-16 weeks) Embryology From ten Donkelaar Clinical Neuroembryology 2010 4mo 6mo 8mo term II. Abnormalities of Hemispheric Cleavage Holoprosencephaly (HPE) Top Mid-sagittal Imaging features: Incomplete hemispheric separation + 1)1) No septum pellucidum in any HPEs Closed Neural
    [Show full text]
  • Table S1. Disease Classification and Disease-Reaction Association
    Table S1. Disease classification and disease-reaction association Disorder class Associated reactions cross Disease Ref[Goh check et al.
    [Show full text]
  • MR Imaging of Fetal Head and Neck Anomalies
    Neuroimag Clin N Am 14 (2004) 273–291 MR imaging of fetal head and neck anomalies Caroline D. Robson, MB, ChBa,b,*, Carol E. Barnewolt, MDa,c aDepartment of Radiology, Children’s Hospital Boston, 300 Longwood Avenue, Harvard Medical School, Boston, MA 02115, USA bMagnetic Resonance Imaging, Advanced Fetal Care Center, Children’s Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA cFetal Imaging, Advanced Fetal Care Center, Children’s Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA Fetal dysmorphism can occur as a result of var- primarily used for fetal MR imaging. When the fetal ious processes that include malformation (anoma- face is imaged, the sagittal view permits assessment lous formation of tissue), deformation (unusual of the frontal and nasal bones, hard palate, tongue, forces on normal tissue), disruption (breakdown of and mandible. Abnormalities include abnormal promi- normal tissue), and dysplasia (abnormal organiza- nence of the frontal bone (frontal bossing) and lack of tion of tissue). the usual frontal prominence. Abnormal nasal mor- An approach to fetal diagnosis and counseling of phology includes variations in the size and shape of the parents incorporates a detailed assessment of fam- the nose. Macroglossia and micrognathia are also best ily history, maternal health, and serum screening, re- diagnosed on sagittal images. sults of amniotic fluid analysis for karyotype and Coronal images are useful for evaluating the in- other parameters, and thorough imaging of the fetus tegrity of the fetal lips and palate and provide as- with sonography and sometimes fetal MR imaging. sessment of the eyes, nose, and ears.
    [Show full text]
  • Effects of DHCR24 Depletion in Vivo and in Vitro
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2006 Effects of DHCR24 depletion in vivo and in vitro Kuehnle, Katrin Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-163476 Dissertation Published Version Originally published at: Kuehnle, Katrin. Effects of DHCR24 depletion in vivo and in vitro. 2006, University of Zurich, Faculty of Science. Effects of DHCR24 Depletion in vivo and in vitro Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Katrin Kuehnle aus Deutschland Promotionskommitee Prof. Esther Stöckli (Vorsitz) PD Dr. M. Hasan Mohajeri (Leitung der Dissertation) Prof. Alex Hajnal Zürich, 2006 It is almost precisely 100 years ago that Auguste D. reported to a German psychiatrist in Frankfurt with the words: ‘I lost myself’. The psychiatrist was none other than Alois Alzheimer, and this day should mark the beginning of Alzheimer’s disease research. Christian Haass, 2004 SUMMARY 9 ZUSAMMENFASSUNG 11 1. INTRODUCTION 13 1.1 ALZHEIMER’S DISEASE 13 1.1.1 THE DISEASE HYPOTHESES 14 1.1.2 APP PROCESSING 15 1.1.3 FAMILIAL ALZHEIMER’S DISEASE (FAD) 17 1.1.4 GENETIC AND NON-GENETIC RISK FACTORS FOR AD 17 1.1.5 CLEARANCE OF AΒETA FROM THE BRAIN 18 1.1.6 TREATMENTS AND POSSIBLE TREATMENT STRATEGIES OF AD 19 1.2 CHOLESTEROL AND AD 21 1.2.1 METABOLISM OF CHOLESTEROL 22 1.2.2 BRAIN CHOLESTEROL 24 1.2.3 CELLULAR MEMBRANES AND LIPID RAFTS 25 1.2.4 CHOLESTEROLS’ INFLUENCE ON APP PROCESSING 26 1.2.5 CHOLESTEROL BIOSYNTHESIS AND TRANSPORT DISORDERS 27 1.2.6 DHCR24 KNOCK-OUT MICE 28 1.2.7 DHCR24/SELADIN-1 29 1.3 AIM OF THE STUDY 31 2.
    [Show full text]
  • Chromosome 13 Introduction Chromosome 13 (As Well As Chromosomes 14, 15, 21 and 22) Is an Acrocentric Chromosome. Short Arms Of
    Chromosome 13 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_13.gif Introduction Chromosome 13 (as well as chromosomes 14, 15, 21 and 22) is an acrocentric chromosome. Short arms of acrocentric chromosomes do not contain any genes. All genes are located in the long arm. The length of the long arm is ~95 Mb. It is ~3.5% of the total human genome. Chromosome 13 is a gene poor area. There are only 600–700 genes within this chromosome. Structural abnormalities of the long arm of chromosome 13 are very common. There are at least 750 patients with deletions of different segments of the long arm (including patients with an associated imbalance for another chromosome). There are several syndromes associated with deletions of the long arm of chromosome 13. One of these syndromes is caused by deletions of 13q14 and neighboring areas. The main manifestation of this syndrome is retinoblastoma. Deletions of 13q32 and neighboring areas cause multiple defects of the brain, eye, heart, kidney, genitalia and extremities. The syndrome caused by this deletion is well known since the 1970’s. Distal deletions of 13q33q34 usually do not produce serious malformations. Deletions of the large area between 13q21 and 13q31 do not produce any stabile and well–recognized syndromes. Deletions of Chromosome 13 Chromosome 13 (as well as chromosomes 14, 15, 21 and 22) belongs to the group of acrocentric chromosomes.
    [Show full text]
  • Prenatalscreen® Standard Technical Report
    About PrenatalScreen® Prenatal Test PrenatalScreen® Prenatal Test is a genetic test that analyses fetal DNA, obtained from CVS or amniotic fluid following an invasive prenatal diagnosis, to screen for monogenic disorders in the fetus. Using the latest technologies, including Next Generation Sequencing (NGS), PrenatalScreen® Prenatal Test screen 744 genes for mutations causing over 1.000 severe genetic disorders in the fetus. PrenatalScreen® Prenatal Test allows for a comprehensive care and enables patients to make more informed reproductive decisions. Offering PrenatalScreen® Prenatal Test to a patient during pregnancy allows her to gain more knowledge about the potential to pass along a condition to the fetus. Aim of the test PrenatalScreen® Prenatal Test analyses DNA extracted from fetal cells in the amniotic fluid, collected through amniocentesis, or in the chorionic villi through villocentesis (CVS). The aim of this diagnositc test is to assess severe genetic diseases in the fetus, including the most common diseases in the European population. Genes listed in Table 1 were selected according to the incidence in the population of the disease caused by mutations in such genes, the severity of the clinical phenotype at birth and the importance of the related pathogenetic picture, in accordance with the indications of the American College of Medical Genetics (ACMG)(Grody et al., Genet Med 2013:15:482–483). PrenatalScreen®: Indication for testing PrenatalScreen® Prenatal Test is intended for patients who meet any of the following criteria: • Personal/familial anamnesis of hereditary genetic diseases; • For expectant mothers wishing to reduce the risk of a genetic diseases in the fetus; • For natural or in vitro fertilization (IVF)-derived pregnancies: • For couples using heterologus IVF procedures (egg/sperm donors).
    [Show full text]
  • Steroidal Triterpenes of Cholesterol Synthesis
    Molecules 2013, 18, 4002-4017; doi:10.3390/molecules18044002 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Steroidal Triterpenes of Cholesterol Synthesis Jure Ačimovič and Damjana Rozman * Centre for Functional Genomics and Bio-Chips, Faculty of Medicine, Institute of Biochemistry, University of Ljubljana, Zaloška 4, Ljubljana SI-1000, Slovenia; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +386-1-543-7591; Fax: +386-1-543-7588. Received: 18 February 2013; in revised form: 19 March 2013 / Accepted: 27 March 2013 / Published: 4 April 2013 Abstract: Cholesterol synthesis is a ubiquitous and housekeeping metabolic pathway that leads to cholesterol, an essential structural component of mammalian cell membranes, required for proper membrane permeability and fluidity. The last part of the pathway involves steroidal triterpenes with cholestane ring structures. It starts by conversion of acyclic squalene into lanosterol, the first sterol intermediate of the pathway, followed by production of 20 structurally very similar steroidal triterpene molecules in over 11 complex enzyme reactions. Due to the structural similarities of sterol intermediates and the broad substrate specificity of the enzymes involved (especially sterol-Δ24-reductase; DHCR24) the exact sequence of the reactions between lanosterol and cholesterol remains undefined. This article reviews all hitherto known structures of post-squalene steroidal triterpenes of cholesterol synthesis, their biological roles and the enzymes responsible for their synthesis. Furthermore, it summarises kinetic parameters of enzymes (Vmax and Km) and sterol intermediate concentrations from various tissues. Due to the complexity of the post-squalene cholesterol synthesis pathway, future studies will require a comprehensive meta-analysis of the pathway to elucidate the exact reaction sequence in different tissues, physiological or disease conditions.
    [Show full text]
  • Disorders of Cholesterol Biosynthesis
    Arch Dis Child 1998;78:185–189 185 CURRENT TOPIC Arch Dis Child: first published as 10.1136/adc.78.2.185 on 1 February 1998. Downloaded from Disorders of cholesterol biosynthesis Peter T Clayton Functions of cholesterol Studies with labelled cholesterol indicate that, Sterols are important constituents of the cell although as much as 20% of fetal cholesterol membranes of most eukaryotic cells. The cell may be derived from the mother at the end of membranes of terrestrial vertebrates, including the first trimester, very little maternal man, contain a single major sterol species— cholesterol enters the fetal brain.56 If the cholesterol. Cholesterol is found particularly in mother is given labelled glucose, the label does external cellular membranes (plasma mem- appear in fetal brain cholesterol and glucose is branes) and in the layers that make up the thought to be the most important fuel for de myelin sheaths in the central and peripheral novo cholesterol synthesis in the fetal brain. In nervous systems. In plasma membranes, the postnatal life, a high cholesterol diet will lead to cholesterol molecules are intercalated between reduced synthesis of cholesterol in the liver. the phospholipid molecules of each monolayer This occurs principally as a result of inhibition and reduce the movement of their acyl chains of the rate limiting step, 3-hydroxy-3-methyl- (reduced “membrane fluidity”). Sterols also CoA (HMG-CoA) reductase, by cholesterol. exert a direct eVect on proteins in the In extrahepatic tissues, the uptake of lipopro- membrane. For example, the function of the tein cholesterol switches oV cholesterol synthe- human red cell hexose transporter is pro- sis in the same way.
    [Show full text]
  • Neuropathology Review.Pdf
    Neuropathology Review Richard A. Prayson, MD Humana Press Contents NEUROPATHOLOGY REVIEW 2 Contents Contents NEUROPATHOLOGY REVIEW By RICHARD A. PRAYSON, MD Department of Anatomic Pathology Cleveland Clinic Foundation, Cleveland, OH HUMANA PRESS TOTOWA, NEW JERSEY 4 Contents © 2001 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel.: 973-256-1699; Fax: 973-256-8341; E-mail:[email protected]; Website: http://humanapress.com All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients.
    [Show full text]
  • Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017
    Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017 Participating members of the Birth Defects Definitions Group: Lorenzo Botto (UT) John Carey (UT) Cynthia Cassell (CDC) Tiffany Colarusso (CDC) Janet Cragan (CDC) Marcia Feldkamp (UT) Jamie Frias (CDC) Angela Lin (MA) Cara Mai (CDC) Richard Olney (CDC) Carol Stanton (CO) Csaba Siffel (GA) Table of Contents LIST OF BIRTH DEFECTS ................................................................................................................................................. I DETAILED DESCRIPTIONS OF BIRTH DEFECTS ...................................................................................................... 1 FORMAT FOR BIRTH DEFECT DESCRIPTIONS ................................................................................................................................. 1 CENTRAL NERVOUS SYSTEM ....................................................................................................................................... 2 ANENCEPHALY ........................................................................................................................................................................ 2 ENCEPHALOCELE ..................................................................................................................................................................... 3 HOLOPROSENCEPHALY.............................................................................................................................................................
    [Show full text]
  • The Cyclops and the Mermaid: an Epidemiological Study of Two Types
    30 0 Med Genet 1992; 29: 30-35 The cyclops and the mermaid: an epidemiological study of two types of rare J Med Genet: first published as 10.1136/jmg.29.1.30 on 1 January 1992. Downloaded from malformation* Bengt Kallen, Eduardo E Castilla, Paul A L Lancaster, Osvaldo Mutchinick, Lisbeth B Knudsen, Maria Luisa Martinez-Frias, Pierpaolo Mastroiacovo, Elisabeth Robert Abstract complex depends on which forms are in- Infants with cyclopia or sirenomelia are cluded, and also on the frequency with which born at an approximate rate of 1 in necropsy is performed on infants dying in the 100 000 births. Eight malformation moni- neonatal period. However, the two extreme toring systems around the world jointly forms, cyclopia and sirenomelia, are easily Department of studied the epidemiology of these rare recognised and usually clearly defined, but Embryology, University of Lund, malformations: 102 infants with cyclopia, both forms are very rare and it is therefore Biskopsgatan 7, S-223 96 with sirenomelia, and one with both difficult to collect material large enough to 62 Lund, Sweden. conditions were identified among nearly permit detailed epidemiological studies. B Kalln 10-1 million births. Maternal age is some- We have collected such material by using ECLAMC/Genetica/ what increased for cyclopia, indicating data from eight malformation monitoring sys- Fiocruz, Rio de Janeiro, Brazil, and the likely inclusion of some chromoso- tems around the world, all members of the IMBICE, Casilla 403, mally abnormal infants which were not International Clearinghouse for Birth Defects 1900 La Plata, identified. About half of the infants are Monitoring Systems,7 and we report some Argentina.
    [Show full text]